Pharmaceutical Executive
A look at what the advent of generic antiretroviral drugs could mean for the industry.
Pharmaceutical Executive-10-11-2005
Pharmaceutical Executive
ABthrax takes advantage of new knowledge about anthrax to fight the bacteria’s lethal toxin.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
